Haynes B, Montefiori D
Expert Rev Vaccines. 2006; 5(3):347-63.
PMID: 16827619
PMC: 2716009.
DOI: 10.1586/14760584.5.3.347.
Zhang L, Mackenzie P, Cleland A, Holmes E, Brown A, Simmonds P
J Virol. 1993; 67(6):3345-56.
PMID: 8497055
PMC: 237678.
DOI: 10.1128/JVI.67.6.3345-3356.1993.
Levy J
Microbiol Rev. 1993; 57(1):183-289.
PMID: 8464405
PMC: 372905.
DOI: 10.1128/mr.57.1.183-289.1993.
Bell G
Genetica. 1993; 91(1-3):21-34.
PMID: 8125270
PMC: 7087926.
DOI: 10.1007/BF01435985.
Itescu S, Simonelli P, Winchester R, Ginsberg H
Proc Natl Acad Sci U S A. 1994; 91(24):11378-82.
PMID: 7972068
PMC: 45234.
DOI: 10.1073/pnas.91.24.11378.
Phase I/II vaccination study of recombinant peptide F46 corresponding to the HIV-1 transmembrane protein coupled with 2.4 dinitrophenyl (DNP) Ficoll.
Schwander S, Opravil M, Luthy R, Hanson D, Schindler J, Dawson A
Infection. 1994; 22(2):86-91.
PMID: 7915256
DOI: 10.1007/BF01739010.
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1.
Muster T, Steindl F, Purtscher M, Trkola A, Klima A, Himmler G
J Virol. 1993; 67(11):6642-7.
PMID: 7692082
PMC: 238102.
DOI: 10.1128/JVI.67.11.6642-6647.1993.
Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.
Kovacs J, Vasudevachari M, Easter M, Davey R, Falloon J, Polis M
J Clin Invest. 1993; 92(2):919-28.
PMID: 7688766
PMC: 294931.
DOI: 10.1172/JCI116667.
Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus.
Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata M, Ohkoshi S
J Virol. 1993; 67(7):3923-30.
PMID: 7685404
PMC: 237759.
DOI: 10.1128/JVI.67.7.3923-3930.1993.
In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop.
Donaldson Y, Bell J, Holmes E, Hughes E, Brown H, Simmonds P
J Virol. 1994; 68(9):5991-6005.
PMID: 7545945
PMC: 237004.
DOI: 10.1128/JVI.68.9.5991-6005.1994.
Relationship between the V3 loop and the phenotypes of human immunodeficiency virus type 1 (HIV-1) isolates from children perinatally infected with HIV-1.
Mammano F, Salvatori F, Ometto L, Panozzo M, Chieco-Bianchi L, De Rossi A
J Virol. 1995; 69(1):82-92.
PMID: 7527089
PMC: 188551.
DOI: 10.1128/JVI.69.1.82-92.1995.
Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS.
Muster T, Guinea R, Trkola A, Purtscher M, Klima A, Steindl F
J Virol. 1994; 68(6):4031-4.
PMID: 7514684
PMC: 236911.
DOI: 10.1128/JVI.68.6.4031-4034.1994.
Heteroduplex mobility assay and phylogenetic analysis of V3 region sequences of human immunodeficiency virus type 1 isolates from Gulu, northern Uganda. The Italian-Ugandan Cooperation AIDS Program.
Buonaguro L, Del Guadio E, Monaco M, Greco D, Corti P, Buonaguro F
J Virol. 1995; 69(12):7971-81.
PMID: 7494310
PMC: 189742.
DOI: 10.1128/JVI.69.12.7971-7981.1995.
Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone.
Franchini G, Fargnoli K, Giombini F, Jagodzinski L, De Rossi A, Bosch M
Proc Natl Acad Sci U S A. 1989; 86(7):2433-7.
PMID: 2648404
PMC: 286927.
DOI: 10.1073/pnas.86.7.2433.
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees.
Nara P, Smit L, Dunlop N, HATCH W, Merges M, Waters D
J Virol. 1990; 64(8):3779-91.
PMID: 2370681
PMC: 249673.
DOI: 10.1128/JVI.64.8.3779-3791.1990.
Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates.
Golub E, Li G, Volsky D
J Virol. 1990; 64(8):3654-60.
PMID: 2370677
PMC: 249658.
DOI: 10.1128/JVI.64.8.3654-3660.1990.
Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain.
Devash Y, Calvelli T, Wood D, Reagan K, Rubinstein A
Proc Natl Acad Sci U S A. 1990; 87(9):3445-9.
PMID: 2333294
PMC: 53917.
DOI: 10.1073/pnas.87.9.3445.
Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeys.
Norley S, Kraus G, Ennen J, Bonilla J, Konig H, Kurth R
Proc Natl Acad Sci U S A. 1990; 87(22):9067-71.
PMID: 2247482
PMC: 55102.
DOI: 10.1073/pnas.87.22.9067.
Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1.
Simmonds P, Balfe P, Ludlam C, Bishop J, Brown A
J Virol. 1990; 64(12):5840-50.
PMID: 2243378
PMC: 248744.
DOI: 10.1128/JVI.64.12.5840-5850.1990.
Persistent infection of rhesus macaques with a molecular clone of human immunodeficiency virus type 2: evidence of minimal genetic drift and low pathogenetic effects.
Franchini G, Markham P, Gard E, Fargnoli K, Keubaruwa S, Jagodzinski L
J Virol. 1990; 64(9):4462-7.
PMID: 2117071
PMC: 247916.
DOI: 10.1128/JVI.64.9.4462-4467.1990.
